Combretum hartmannianum
Combretum hartmannianum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Combretum hartmannianum is a botanical species recognized for its significant pharmacological potential in addressing various health conditions. Research indicates that extracts derived from its leaves and stems exhibit notable antiproliferative activities. Specifically, the presence of the chemical compound terchebulin plays a crucial role in its biological efficacy. These plant components are often utilized in various preparations, including bark, decoctions, leaf extracts, and macerations. Consequently, this plant shows promise in therapeutic strategies targeting neoplasia and oxidative stress.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Stem
Classification
Taxonomy
Combretum hartmannianum is a distinctive member of the kingdom Plantae. This species is classified under the class Equisetopsida, showcasing its fundamental botanical structure. Within this broad grouping, it belongs to the order Myrtales. It is further categorized into the family Combretaceae, which defines many of its specific biological traits. Ultimately, this plant is identified by its specific genus, Combretum, marking its unique place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Combretum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Combretum hartmannianum is a distinctive plant species with a primary distribution spanning across the African continent. It is notably found throughout the diverse landscapes of Northeast Tropical Africa. Within this region, the species thrives in specific territories such as Eritrea and Ethiopia. Its presence also extends into the areas of Sudan and South Sudan, marking a significant ecological footprint. This wide geographical range highlights the plant's adaptability to various environments within these East African nations.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Combretum hartmannianum is a self-supporting tree that establishes a sturdy presence in its natural habitat. This species exhibits a robust growth form, allowing it to reach impressive dimensions. It can achieve a maximum height of up to 25 meters as it matures.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Combretum hartmannianum has demonstrated significant antiproliferative activity against specific human cancer cell lines. In recent studies involving Sudanese medicinal plants, this species showed remarkable effectiveness in inhibiting the growth of both MCF-7 breast cancer and HCT 116 colon cancer cells. The research utilized the MTT assay to determine that the plant's extracts could target malignant cells while remaining non-cytotoxic to normal human cells. Specifically, the IC50 values for Combretum hartmannianum were measured at 8.48 μg/ml against breast cancer and 27.2 μg/ml against colon cancer. These promising biological findings support the traditional ethnobotanical use of the plant and warrant further investigation into its active medicinal principles.
Compounds
Combretum hartmannianum has emerged as a significant plant in the study of periodontal disease prevention due to its potent bioactive properties. Researchers investigating the bark of this species successfully utilized various chromatographic and spectroscopic methods to isolate several key compounds. Among these findings, the study identified that Combretum hartmannianum contains terchebulin, a compound that was isolated for the first time in this research. This specific molecule demonstrated the ability to significantly inhibit the matrix metalloproteinase-9 enzyme, which is a major contributor to tissue destruction. Consequently, the presence of terchebulin makes this plant a promising natural candidate for the development of new treatments against oral infections.
Conditions
Combretum hartmannianum demonstrates significant medicinal potential by treating the chloroquine-sensitive P. falciparum strain (NF54) through various plant extracts. The leaf extracts of this species are capable of totally inhibiting the HIV-1 reverse transcriptase (HIV-1 RT) enzyme. Furthermore, the plant serves as a treatment for periodontal issues by acting against P. gingivalis bacteria and inhibiting the MMP-9 enzyme. Its bark also contains bioactive compounds like terchebulin that contribute to these antibacterial and enzymatic inhibitory effects. Finally, Combretum hartmannianum shows promise in treating neoplasia due to its remarkable anti-angiogenic and antiproliferative activities against human cancer cells.
Preparations
Combretum hartmannianum is prepared as bark, stem, and leaves for various medicinal applications. In Sudanese traditional medicine, the plant is prepared as decoctions and macerations to treat persistent coughs. Extracts from the bark and stem show significant activity against chloroquine-sensitive malaria strains. The leaves are also utilized, specifically demonstrating the ability to inhibit the HIV-1 reverse transcriptase enzyme. These diverse preparation methods and plant parts highlight the ethnopharmacological importance of the species.
Parts used
Combretum hartmannianum is a notable medicinal plant species that exhibits significant biological activities across its various morphological structures. Research indicates that the stem of this plant possesses potent antiplasmodial properties against the chloroquine-sensitive P. falciparum strain. Furthermore, the leaves of the species demonstrate a different range of therapeutic potential, including a notable inhibitory effect on the enzyme HIV-1 reverse transcriptase. These findings highlight how different plant parts, specifically the stem and the leaf, contribute unique medicinal values to the organism. Such diverse chemical profiles underscore the importance of studying the specific anatomical components of Combretum hartmannianum for drug development.